Wei Bu

3.0k total citations
75 papers, 1.8k citations indexed

About

Wei Bu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Wei Bu has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Wei Bu's work include Viral-associated cancers and disorders (15 papers), Parvovirus B19 Infection Studies (6 papers) and Herpesvirus Infections and Treatments (6 papers). Wei Bu is often cited by papers focused on Viral-associated cancers and disorders (15 papers), Parvovirus B19 Infection Studies (6 papers) and Herpesvirus Infections and Treatments (6 papers). Wei Bu collaborates with scholars based in China, United States and Taiwan. Wei Bu's co-authors include Jeffrey I. Cohen, Vinay K. Pathak, Jean L. Mbisa, Gary J. Nabel, Masaru Kanekiyo, Adrian B. McDermott, Michael G. Rossmann, Michael Joyce, David M. Lukac and Diana Palmeri and has published in prestigious journals such as Nature, Cell and Immunity.

In The Last Decade

Wei Bu

68 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Bu China 26 474 471 470 276 262 75 1.8k
Subhra Mohapatra United States 31 486 1.0× 413 0.9× 1.2k 2.6× 339 1.2× 224 0.9× 112 3.3k
Yohan Kim United States 35 335 0.7× 500 1.1× 1.1k 2.4× 512 1.9× 259 1.0× 141 3.8k
Suzanne Thomas United Kingdom 20 625 1.3× 309 0.7× 942 2.0× 415 1.5× 107 0.4× 49 2.1k
Zhenyu Sun China 29 253 0.5× 143 0.3× 1.3k 2.7× 509 1.8× 258 1.0× 79 2.7k
Hervé Drobecq France 36 465 1.0× 464 1.0× 2.3k 5.0× 622 2.3× 357 1.4× 122 4.4k
Qianqian Zhu China 35 437 0.9× 458 1.0× 1.9k 4.1× 549 2.0× 171 0.7× 159 3.9k
Jiaxin Wu China 22 312 0.7× 141 0.3× 618 1.3× 312 1.1× 171 0.7× 131 1.7k
Luca Varani Switzerland 27 554 1.2× 225 0.5× 1.4k 3.1× 1.3k 4.6× 573 2.2× 51 3.8k
Javid Sadri Nahand Iran 38 459 1.0× 485 1.0× 2.3k 5.0× 478 1.7× 380 1.5× 96 3.8k
Xiaodong Xu China 29 199 0.4× 596 1.3× 736 1.6× 307 1.1× 304 1.2× 94 2.2k

Countries citing papers authored by Wei Bu

Since Specialization
Citations

This map shows the geographic impact of Wei Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Bu more than expected).

Fields of papers citing papers by Wei Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Bu. The network helps show where Wei Bu may publish in the future.

Co-authorship network of co-authors of Wei Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Bu. A scholar is included among the top collaborators of Wei Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Bu. Wei Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bu, Wei, Yujuan Dong, Yuling Wang, et al.. (2025). Downregulation of Nrf2 deteriorates cognitive impairment in APP/PS1 mice by inhibiting mitochondrial biogenesis through the PPARγ/PGC1α signaling pathway. Behavioural Brain Research. 495. 115805–115805. 1 indexed citations
2.
Bu, Wei, Wei‐Hung Chen, Rebecca A. Gillespie, et al.. (2025). Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350. Immunity. 58(2). 295–308.e5. 3 indexed citations
3.
Xie, Zhipeng, Lu Wang, Yuhui Cheng, et al.. (2025). Dual-target stabilization and antifouling via S-scheme Cu2O@TiO2 heterojunction for robust marine coating under illumination. Surface and Coatings Technology. 511. 132254–132254. 1 indexed citations
4.
Pan, Jingjing, et al.. (2025). Prediction of mortality risk in patients with severe community-acquired pneumonia in the intensive care unit using machine learning. Scientific Reports. 15(1). 1566–1566. 5 indexed citations
5.
Bu, Wei, Ashish Kumar, Kennichi Dowdell, et al.. (2024). Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells. Immunity. 57(3). 559–573.e6. 15 indexed citations
6.
Bu, Wei, Qin Yu, Cui Wang, et al.. (2024). Activation and functional modification of mucosal-associated invariant T cells in patients with intracranial infection following craniotomy. International Immunopharmacology. 130. 111699–111699. 1 indexed citations
7.
Yang, Xiaofang, Miao Yu, Dawei Yang, et al.. (2023). UPLC-Q TOF-MS-Based metabolomics and anti-myocardial ischemia activity of Dioscoreae Nipponicae Rhizoma from different geographical origins. Journal of Pharmaceutical and Biomedical Analysis. 234. 115551–115551. 7 indexed citations
8.
Pan, Jingjing, Wei Bu, Tao Guo, Zhi Geng, & Min Shao. (2023). Development and validation of an in-hospital mortality risk prediction model for patients with severe community-acquired pneumonia in the intensive care unit. BMC Pulmonary Medicine. 23(1). 303–303. 6 indexed citations
9.
Li, Rui, Chenchen Zhang, Bonan Li, et al.. (2023). Molecular confined synthesis of magnetic CoOx/Co/C hybrid catalyst for photocatalytic water oxidation and CO2 reduction. Chinese Chemical Letters. 34(12). 108801–108801. 38 indexed citations
10.
Wei, Chih‐Jen, Wei Bu, Laura A. Nguyen, et al.. (2022). A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice. Science Translational Medicine. 14(643). eabf3685–eabf3685. 64 indexed citations
11.
Bu, Wei, Sohtaro Mine, Zeshan Tariq, et al.. (2021). Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV. Virology. 561. 80–86. 4 indexed citations
12.
13.
Huang, Jinjin, et al.. (2020). Ultrasound-assisted hydrolysis of lard for free fatty acids catalyzed by combined two lipases in aqueous medium. Bioengineered. 11(1). 241–250. 27 indexed citations
14.
Huang, Jinjin, Qing Wang, Wei Bu, et al.. (2019). Different construction strategies affected on the physiology of Pichia pastoris strains highly expressed lipase by transcriptional analysis of key genes. Bioengineered. 10(1). 150–161. 5 indexed citations
15.
Bu, Wei, Michael Joyce, Hanh Nguyen, et al.. (2019). Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells. Immunity. 50(5). 1305–1316.e6. 129 indexed citations
16.
Li, Qingxue, Wei Bu, Erin E. Gabriel, et al.. (2017). HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells. JCI Insight. 2(4). e85687–e85687. 10 indexed citations
17.
Coghill, Anna E., Wei Bu, Hanh Nguyen, et al.. (2016). High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clinical Cancer Research. 22(14). 3451–3457. 32 indexed citations
18.
Kanekiyo, Masaru, Wei Bu, Michael Joyce, et al.. (2015). Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site. Cell. 162(5). 1090–1100. 258 indexed citations
19.
Bu, Wei, Tsutomu Akama, Sanjay Chanda, et al.. (2012). Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discovery. Journal of Pharmaceutical and Biomedical Analysis. 70. 344–353. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Subhra Mohapatra Breakdown of academic impact, for papers by Yohan Kim Breakdown of academic impact, for papers by Suzanne Thomas Breakdown of academic impact, for papers by Zhenyu Sun Breakdown of academic impact, for papers by Hervé Drobecq Breakdown of academic impact, for papers by Qianqian Zhu Breakdown of academic impact, for papers by Jiaxin Wu Breakdown of academic impact, for papers by Luca Varani Breakdown of academic impact, for papers by Javid Sadri Nahand Breakdown of academic impact, for papers by Xiaodong Xu
Rankless by CCL
2026